Alzheimer's precision medicine aims to tailor treatments to the specific genetic, molecular, and clinical characteristics of individuals affected by Alzheimer’s disease and dementia. By leveraging advancements in genetics, biomarkers, and neuroimaging, researchers seek to identify personalized therapies that can effectively slow disease progression or alleviate symptoms based on each patient’s unique profile.
This approach contrasts with traditional one-size-fits-all treatments, recognizing the complex and varied nature of Alzheimer's disease among different individuals. Precision medicine in Alzheimer's holds promise in predicting disease risk, selecting appropriate interventions, and optimizing therapeutic outcomes, ultimately striving towards more targeted and effective care strategies. As research continues to uncover deeper insights into the underlying mechanisms of Alzheimer's, the development and application of precision medicine approaches offer hope for more personalized and impactful treatments in the future.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China